Emile Voest is medical oncologist, senior group leader at the Netherlands Cancer Institute, senior scientist of the Oncode Institute, and translational scientist. He is the current director of Cancer Core Europe, a collaboration of 7 excellent comprehensive cancer centers. His laboratory group is devoted to bringing precision medicine to patients and is focused on mechanistic studies of tumor biology, immunology and applying computational science and genomics to better understand how tumors respond to certain treatments. The results from these studies are subsequently tested for their value in patients. These translational approaches are performed across tumor types with emphasis on epithelial tumors.
His research is in the area of precision medicine and consists of large scale genomic sequencing of patients with metastatic cancer, the development of co-culture models of primary cultures of tumors (i.c. organoids) and immune cells to improve drug development and immunotherapy and to determine which treatment is best for a specific patient via computational, integrated approaches.